New Guidance for Amyloid and Tau PET Imaging Released

Jan. 30, 2025 – Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimer’s disease and other dementias. The new criteria expand PET imaging guidance to include tau PET, incorporate updated information, and provide specific guidance to enhance diagnostic precision, treatment decisions, and patient care.